In vitro experiments with synovial fibroblasts from patients with RA have demonstrated a metabolic shift toward glycolysis, increased expression of intercellular adhesion molecule 1, and secretion of IL-6 in response to combined treatment with TGF-β and IL-1β. Here, IL6 is linked to rheumatoid arthritis.